The Patent Finder
MT

Modulation Therapeutics

First filing 2014
OverviewNotableFeesChangesFamiliesPatent listSources & methods

One patent currently held, every record listed here

4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jun 2039. from the record

Of the 4 now held by other companies, 2 name University of Florida Reasearch Foundation Incorporated as their current owner, and 2 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jun 2039
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2018 to 2039.
US 10,011,635 Cyclic Peptide Conjugates and Methods of Use Sep 26, 2034
US 11,078,235 Cyclic Peptide Conjugates and Methods of Use Sep 26, 2034
US 11,406,723 Radiotherapeutic and Companion Imaging Agents to Target MC1R May 6, 2036
US 12,508,329 Radiotherapeutic and Companion Imaging Agents to Target MC1R May 6, 2036
US 12,060,438 Cyclic Peptide Compounds and Methods of Use Thereof Jun 5, 2039
202220262030203420382039
4 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2034.
Ends Sep 2034 · High confidence
Also notable Ends May 2036 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 1 of 1

PatentTitleStatusExpiresConfidence
US 12,060,438Cyclic Peptide Compounds and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 1: 4 patents in force now held by others · 4 applications pending · 3 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited